정책동향
BioTOP-Report : Biotech and Pharma in Berlin-Brandenburg
- 등록일2014-08-04
- 조회수5601
- 분류정책동향 > 기타 > 기타
-
자료발간일
2014-06-06
-
출처
http://www.healthcapital.de/biotechnologie/
- 원문링크
-
키워드
#독일#German
- 첨부파일
베를린 브란덴부르크 생명공학 및 제약
독일 수도권 - 생명공학과 생명과학의 미래를 위한 준비
The German Capital Region ? Biotechnology and Life Sciences are Ready for the Future
Berlin-Brandenburg is an extremely attractive location for research and its translation into industrial applications. The establishment of the Berlin Institute of Health, successful spin-offs and inward investment show that the German capital region provides top conditions for the healthcare industry. Berlin is the -up capital of Germany!
With its new “Healthcare Industries” master plan, the capital region is setting the course for the sector’s development until 2018. Basic research, innovation, spin-offs and application ? in the future, these will remain the four pillars that determine the successful implementation of the cluster strategy in Berlin-Brandenburg.
Biotechnology/pharmaceuticals, medical technology and the healthcare industries are the focal areas. In the coming years, biotechnology/pharmaceuticals development will feature:
....(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
-
이전글
- 벤처캐피털 활성화를 통한 벤처기업 육성 정책
-
다음글
- Investing in Science, Engineering, and Education for the Nation's Future - National Science Foundation Strategic Plan for 2014-2018
지식